Prospective Study of Intensity-Modulated Proton Therapy (IMPT) for Small Cell Lung Cancer
Recruiting · NCT04342429 · Interventional (participants receive a specific treatment)
View the official record on ClinicalTrials.gov →Interventions studied
Proton-beam Therapy for Small Cell Lung Cancer
What this trial is about
To assess the safety and efficacy of intensity-modulated proton therapy (IMPT) for small cell lung cancer (SCLC)
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Pathologically confirmed small cell lung cancer, limited or extensive stage.
- Patients who are offered thoracic radiotherapy with intensity-modulated proton therapy (IMPT) techniques delivering 30-66 Gy in 15-33 fractions at 2 Gy per fraction, at the recommendation of the treating radiation oncologist.
- Age 18 or greater
Exclusion criteria
- Prior radiation therapy which would provide significant dose overlap with the planned target volume(s)
- Pregnancy
Where it is running
1 location listed across 1 US state.
- Winship Cancer Institute - Atlanta, Georgia, United States